Investor · Paramus, NJ

Ashish C. Sevak

Open Ashish in the network graph →

Filings

11

SEC Form D

Connections

49

co-filers

Capital

$21.0M

across filings

Active

Feb 2019

to Aug 2023

Most-connected co-filers (49)

Conor M. Mahlmann · Chicago, IL8 shared Heyward Coleman · Coralville, IA5 shared Curtis Nelson · Coralville, IA5 shared Steven J. Klein · Cashmere, WA5 shared Frances Johnson · Coralville, IA5 shared Stephen Randall · Toronto, Ontario, Canada5 shared Dean Didato · Seward, NE5 shared Karen J. Say-Valdez · Cashmere, WA5 shared Virginia Emery · Cashmere, WA5 shared Jeff Garden · Los Angeles, CA5 shared Michael Schultz · Coralville, IA5 shared Martin J. Gibson · London, United Kingdom3 shared Timothy J. Bunting · London, United Kingdom3 shared Stephen H. Hsu · OKEMOS, MI3 shared Stephen J. Chandler · London, United Kingdom3 shared John H. Burbank · San Francisco, CA3 shared Hiroki J. Takeuchi · London, United Kingdom3 shared Cameron Blackmon · Fort Worth, TX3 shared Jeffrey W. Brown · Bryan, TX3 shared John E. Jordan · Bryan, TX3 shared Mike E. Labarre · Nashville, TN3 shared Kenneth J. Kelley · Nashville, TN3 shared David R. Mittelman · Boston, MA3 shared Cameron Gray · San Mateo, CA3 shared

Recent filings (11)

Nivagen Pharmaceuticals, Inc.Aug 2023 · 17 co-filers$5.0M Groupay Inc.Feb 2021 · 23 co-filers$105.0M Viewpoint Molecular Targeting, Inc.Jan 2021 · 14 co-filers$15.8M Viewpoint Molecular Targeting, Inc.Dec 2020 · 14 co-filers$15.8M Groupay, Inc.Dec 2020 · 17 co-filers$95.0M Viewpoint Molecular Targeting, Inc.Dec 2020 · 14 co-filers$15.8M Viewpoint Molecular Targeting, Inc.Jun 2020 · 11 co-filers$2.0M Nivagen Pharmaceuticals, Inc.May 2020 · 11 co-filers$16.0M Groupay, Inc.Feb 2019 · 14 co-filers$75.5M Viewpoint Molecular Targeting, Inc.Feb 2019 · 11 co-filers$2.0M Nivagen Pharmaceuticals, Inc.Sep 2017 · 4 co-filers$10.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Ashish in the interactive graph →